Copyright
©The Author(s) 2025.
World J Clin Oncol. Mar 24, 2025; 16(3): 94091
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.94091
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.94091
Characteristics | Low expression of TMC5 (n = 187) | High expression of TMC5 (n = 187) | P value |
Gender | 0.036 | ||
Female | 51 (13.64) | 70 (18.72) | |
Male | 136 (36.36) | 117 (31.28) | |
Age | 0.499 | ||
≤ 60 | 92 (24.60) | 85 (22.73) | |
> 60 | 95 (25.40) | 101 (27.01) | |
Stage | 0.029 | ||
I | 99 (26.47) | 74 (19.79) | |
II | 40 (10.70) | 12.57 (12.57) | |
III | 41 (10.96) | 44 (11.76) | |
IV | 0 | 5 (1.34) | |
T stage | 0.023 | ||
T1 | 101 (27.01) | 82 (34) | |
T2 | 42 (11.23) | 53 (16.3) | |
T3 | 39 (10.43) | 41 (10.96) | |
T4 | 2 (0.53) | 11 (2.94) | |
N stage | 1.000 | ||
N0 | 134 (35.83) | 120 (32.09) | |
N1 | 2 (0.27) | 2 (0.27) | |
M stage | 0.120 | ||
M0 | 139 (37.17) | 129 (34.49) | |
M1 | 0 | 4 (1.07) |
- Citation: Li J, Wang ZY, Jin Y, Xu J, Ya YJ, Wan TQ, Li X, Wang X. Transmembrane channel-like 5 drives hepatocellular carcinoma progression by regulating epithelial-mesenchymal transition. World J Clin Oncol 2025; 16(3): 94091
- URL: https://www.wjgnet.com/2218-4333/full/v16/i3/94091.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i3.94091